Hampstead Holdings

Hampstead Holdings is a Bermuda-incorporated holding company primarily known for its strategic role in the medical cannabis and pharmaceutical sector within Latin America and the Caribbean. The company gained significant industry attention when it was acquired by Aphria (now part of Tilray) in 2018 as part of a major expansion into international markets. Through its subsidiary, Marigold Projects Jamaica Limited, Hampstead Holdings holds critical licenses for the cultivation, processing, and distribution of medical cannabis products. Its business model focuses on leveraging regional licenses to provide therapeutic and pharmaceutical-grade cannabis solutions to global markets. The company's assets are now integrated into Tilray's global supply chain, supporting research and commercialization of cannabinoid-based therapies.